CBUS News & Events

Cibus announced its participation as a key technology partner in a research and development project funded by the UK Government's Department for Environment, Food & Rural Affairs. Announced this week, the project is part of the Farming Innovation Programme, with Defra investing in mid-stage precision breeding projects designed to strengthen the resilience and productivity of UK agriculture. Cibus will apply its proprietary gene-editing expertise to address the sustainable protection of oilseed rape against Light Leaf Spot disease. "We are excited to be chosen for this critical program and to support the UK's vision for a more resilient agricultural sector," said Tony Moran, Senior Vice President of International Development at Cibus. "By integrating our precision breeding technology with the world-class research at the John Innes Centre and the University of Hertfordshire, the project aims to provide a vital tool for farmers. Our Rapid Trait Development System enables precise gene edits in elite OSR breeding lines, significantly shortening the time needed to bring new traits to market."

Cibus announced the pricing of an underwritten public offering of 13,333,333 shares of its Class A Common Stock, par value $0.0001 per share, at a public offering price of $1.50 per share. Members of Cibus' Board of Directors will purchase 1,000,000 shares of Class A Common Stock in the Offering at the public offering price. The Company has also granted the underwriter a 30-day option to purchase up to an additional 1,999,999 shares of Class A Common Stock to cover over-allotments, if any. All shares of Class A Common Stock to be sold in the Offering are to be sold by the Company. The gross proceeds of the Offering will be approximately $20M before deducting underwriting discounts and commissions in the Offering and other estimated expenses payable by the Company. The Offering is expected to close on January 30, 2026, subject to the satisfaction of customary closing conditions. BTIG is acting as the sole underwriter for the Offering.

Cibus announced that it intends to offer shares of its Class A common stock in an underwritten public offering. Members of Cibus' board have indicated an interest in purchasing shares of Class A Common Stock in the offering. Because these indications of interest are not binding agreements or commitments to purchase, those certain persons may elect not to purchase any shares in the offering, or the underwriter may elect not to sell any shares in the offering to those certain persons. Cibus currently intends to use the net proceeds from the offering for working capital and general corporate purposes, including to fund further development of its weed management traits in Rice and to pay accrued professional expenses for advisory services. BTIG is acting as the sole underwriter for the offering.